Epigenetic Vulnerability in Acute Myeloid Leukemia Exposed
Acute myeloid leukemia (AML) is an aggressive blood cancer that causes uncontrolled accumulation of white blood cells. Researchers at Baylor College of Medicine and collaborating institutions report they have uncovered a new vulnerability of this cancer that can be targeted with a class of experimental drugs.
Source: genengnews.com